Exploring the potential of MSCs in cancer therapy
A new review was published in Oncotarget's Volume 15 on November 22, 2024, entitled "Mesenchymal stem cells – the secret agents of cancer ...
Tag: T-Cell
New immune therapy improves survival and reduces tumor burden in glioblastoma
The Wistar Institute's David B. Weiner, Ph.D. -; Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable ...
Phase 1 study finds serine- and glycine-free diet boosts immune response in colorectal cancer
Early trial shows a specialized diet enhances immune cell activity and improves the effectiveness of immunotherapy in colorectal cancer patients ...
P-stalk ribosomes identified as key regulators of immune evasion in cancer
New study reveals that specialized ribosomes, driven by cytokine signals, help tumors evade the immune system, offering a breakthrough pathway ...
Long-lived plasma cells fail to establish after COVID mRNA vaccination, limiting long-term antibody response
Researchers discover that COVID-19 mRNA vaccines do not generate long-lasting plasma cells in the bone marrow, shedding light on why ...
Researchers gain new understanding of how immune cells respond to heat during fever
Study reveals that moderate fever temperatures (39°C) improve metabolism, proliferation, and effector function of CD4 T cells while reducing regulatory ...
New two-dose HIV vaccine strategy shows promise for stronger immune response
One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very ...
Overcoming cancer relapse with CAR-Enhancer therapy
Even as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a ...
CD5 knockout using CRISPR boosts CAR T cell therapy efficacy
The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by ...
CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma
CAR-T cell therapy, which targets a specific protein on the surface of cancer cells, causes tumors to shrink or disappear ...
